67건 · 관련도순
Analyze defense program budgets and acquisition costs — earned value management (EVM/CPI/SPI), should-cost modeling, PPBE process alignment, cost estimation per GAO guidelines, Nunn-McCurdy breach risk, FYDP profiles, and learning curve analysis. Audit DoD 5000 acquisition software, program cost databases, and budget justification systems.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Drafts post-judgment motions for attorneys' fees using the lodestar method. Covers prevailing party analysis, rate justification, hours documentation, billing judgment, lodestar enhancements, and supporting declarations. Trigger when user needs a fee motion, fee petition, lodestar calculation, or post-trial fee application.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Identifies missing tests for critical paths (Money 20+, Security 20+, Data Integrity 15+, Core Flows 15+). Returns list of untested critical business logic with priority justification.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when auditing or fixing prose that reads like a leaked reasoning transcript — dead design-session citations such as (decision N), audit item codes, or §N of uncommitted drafts; change narration such as "used to", "no longer", "this cut"; stack or review vantage ("a later PR in this stack", "rejected in review"); reviewer-addressed justifications; control-flow narration; or hedged planning residue in comments, JSDoc, docs, or Agent Notes.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when a developer needs a ChatGPT Apps submission import file from an MCP server. Inspect the implementation, generate chatgpt-app-submission.json with app info, tool-hint justifications, positive and negative test cases, then report review findings and outputSchema warnings.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Generate formal IT/hardware purchase request documents from informal requirements. Use when creating purchase justifications, cost-benefit analyses, ROI calculations, vendor comparisons, or MARP presentation slides for management approval.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Evaluate plan.md design decisions for dominant-axis misalignment using the Decision Quality framework. Detects when a plan optimizes for the wrong evaluation axis given the nature of the change. Use during plan review alongside logic-validator and scope-justification-reviewer.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Prepares a change request pack (description and justification, scope, schedule, implementation plan, risk as stated, rollback, test evidence as provided, communications, approvals route) from an engineer's notes, ticket or pull request description, with UNKNOWN for anything not provided and a question list for the engineer. Never rates risk or marks a change tested or approved. Use when the user asks to "write the change request for this", "fill in the change ticket from my notes", "prepare the CAB submission" or "turn this pull request into an RFC". Do not use for the step-by-step procedure with commands and rollback, use runbook-drafter instead; for release notes describing what shipped, use release-notes-writer. Drafts for human review; never approves, authorises or signs off.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Pre-checks one expense claim or travel plan, line by line, against the expense or travel policy the user supplies, and returns a DRAFT precheck sheet: the policy clause matched to each line, the limit quoted as the policy states it, whether the amount sits within, at or outside that limit, missing receipts, pre-approvals or justifications, and neutral questions for the approver and the claimant, with UNKNOWN wherever the policy or the claim is silent. Use when the user asks to "check this expense claim against policy", "pre-check my travel request", "is this claim within policy", "review these expenses before I submit them", "what receipts or approvals are missing" or "prepare the approver's questions for this claim". Do not use for a purchase order log or spend extract, use purchase-order-anomaly-review instead; do not use to compare a policy against a standard or regulation, use policy-gap-review instead. Drafts for human review; never approves, authorises or signs off.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Run the refactor workflow — mandatory architectural justification, test verification, risk-based implementation, and scope enforcement.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Quantifies biodiversity from species abundance/incidence tables using Hill numbers (iNEXT) with coverage-based rarefaction-extrapolation (Chao & Jost 2012), asymptotic richness via Chao1/ACE/jackknife as a lower bound, Baselga turnover/nestedness partition with the Podani alternative as sensitivity check, mandatory Hellinger transformation before ordination (Legendre & Gallagher 2001), Faith PD and SES_MPD/SES_MNTD with explicit null-model choice, and Maire 2015 functional-diversity dimensionality optimization. Use when comparing diversity across sites with unequal sampling effort, picking the right richness estimator for singleton-heavy amplicon data, partitioning beta diversity into turnover vs nestedness, reporting Hill-number effective species counts rather than raw entropies, computing SES_MPD with explicit null-model justification, or deciding whether to apply standard metrics to compositional amplicon data. Not for clinical 16S microbiome diversity (see microbiome/diversity-analysis).
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when a research proposal needs work packages, milestones, deliverables, a timeline, a risk register, and budget-justification scaffolding, while keeping scientific claims and feasibility honest and human-owned.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Penetration test and red team report writing methodology. Covers executive summary structuring (risk-led narrative for non-technical readers), technical finding format (title, severity, affected scope, narrative, reproduction steps, impact, remediation, references), CVSS v3.1 / v4.0 scoring with vector justification, OWASP risk rating, evidence hygiene (redacting credentials, hashing client data, time-stamping every action), screenshot and PoC artifact management, finding chain narratives, scope/limitations/assumptions documentation, retest evidence and remediation tracking, deliverable formats (PDF, DOCX, HTML, JSON for SIEM ingestion), client-customer-deliverable separation, and common report mistakes (over-CVSSing, undermining the triager, missing the 'so what'). Use at the end of an engagement when authoring a deliverable, when restructuring a draft for executive readability, or when establishing a reusable report template for a consulting practice.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.